We are live on ! Find out more
MPLT

MapLight Therapeutics
MPLT

74 hedge funds and large institutions have $405M invested in MapLight Therapeutics in 2025 Q4 according to their latest regulatory filings, with 74 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50.84% more ownership

Funds ownership: 0% → 50.84% (+51%)

Holders
74
Holders Change
+74
Holders Change %
–
% of All Funds
0.9%
Holding in Top 10
8
Holding in Top 10 Change
+8
Holding in Top 10 Change %
% of All Funds
0.1%
New
74
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NHAS
Novo Holdings A/S
Denmark
+$61.8M
2
FIS
FCPM III Services
Netherlands
+$54.1M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$46.9M
4
Goldman Sachs
Goldman Sachs
New York
+$32.5M
5
BlackRock
BlackRock
New York
+$18.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NHAS
1
Novo Holdings A/S
Denmark
$64.8M +$61.8M +3,686,622 New
FIS
2
FCPM III Services
Netherlands
$56.7M +$54.1M +3,226,400 New
T. Rowe Price Investment Management
3
T. Rowe Price Investment Management
Maryland
$49.2M +$46.9M +2,799,180 New
Goldman Sachs
4
Goldman Sachs
New York
$34M +$32.5M +1,937,168 New
BlackRock
5
BlackRock
New York
$19.2M +$18.4M +1,095,514 New
NFGH
6
Nan Fung Group Holdings
Hong Kong
$17.1M +$16.3M +971,253 New
5VM
7
5AM Venture Management
California
$16.7M +$15.9M +950,011 New
S
8
Sanofi
France
$16M +$15.3M +912,041 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$15.3M +$14.6M +869,668 New
PBPIA
10
Pivotal bioVenture Partners Investment Advisor
California
$10.7M +$10.2M +611,447 New
PA
11
Perceptive Advisors
New York
$9.66M +$9.21M +550,000 New
VCIM
12
Velan Capital Investment Management
Georgia
$9.17M +$8.75M +522,305 New
SL
13
Siren LLC
Connecticut
$7.9M +$7.54M +450,000 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$6.83M +$6.52M +389,026 New
VPC
15
Vestal Point Capital
New York
$6.76M +$6.45M +385,000 New
BBA
16
Baker Bros. Advisors
New York
$6.41M +$6.11M +364,705 New
JG
17
Jain Global
New York
$5.76M +$5.49M +327,693 New
BOCH
18
Blue Owl Capital Holdings
New York
$5.74M +$5.48M +327,058 New
State Street
19
State Street
Massachusetts
$4.03M +$3.84M +229,484 New
Lazard Asset Management
20
Lazard Asset Management
New York
$3.64M +$3.48M +207,494 New
BOTOTLSJU
21
Board of Trustees of The Leland Stanford Junior University
California
$3.5M +$3.34M +199,233 New
Citadel Advisors
22
Citadel Advisors
Florida
$3.34M +$3.19M +190,139 New
FGP
23
Freestone Grove Partners
California
$3.23M +$3.08M +183,771 New
TAM
24
TFG Asset Management
Cayman Islands
$2.89M +$2.76M +164,525 New
BNP Paribas Asset Management
25
BNP Paribas Asset Management
France
$2.6M +$2.48M +147,930 New
1
2 3

MPLT Hedge Fund Activity: Q4 2025 in Review

74 of the 8,256 institutional investors tracked by Wall St. Rank reported a position in MapLight Therapeutics (MPLT) for Q4 2025, worth a combined $405M.

Buyers outnumbered sellers: 74 funds opened new MPLT positions and 0 closed out — a net gain of 74 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Novo Holdings A/S, opening a new position worth an estimated $61.8M.

  • 74 institutional investors held MapLight Therapeutics (MPLT) as of Q4 2025, up from 0 in Q3 2025.
  • Funds reported $405M of MapLight Therapeutics stock for Q4 2025.
  • 74 funds opened new MapLight Therapeutics positions in Q4 2025 and 0 closed out, a net change of +74 holders.
  • The largest MapLight Therapeutics buyer in Q4 2025 was Novo Holdings A/S, an estimated $61.8M added.

Based on aggregated 13F filings for Q4 2025.